Corrigendum to ‘Comparison of the PK, PD, safety, tolerability, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab in healthy Japanese males: a phase 1, randomised, crossover study’ [EULAR Rheumatology Open 1 (2025) 282–290]

EULAR Rheumatology Open · Elsevier

Аннотация

Publication date: December 2026 Source: EULAR Rheumatology Open, Volume 2, Issue 4 Author(s): Tomoko Hasunuma, Paul Emery, Ernest Choy, Masato Okada, Roshan Dias, Károly Horvát-Karajz, Gordana Dancer, Attila Kónya, Yusuke Karibe, Kazuya Uchida, Suguru Masuda, Joachim Kiefer, Gerd R. Burmester

Читать у издателя →

Похожие статьи